Micropore Technologies

A brief introductory video explaining Micropore's unique membrane-based system

Our Unique Technology

Single Device
The AXF™mini. One device for discovery, preclinical & clinical stages. Start at 0.5mL or less. Turn it up to 10-20mL. And finally up-scale to 100’s mL.
Scale-up Made Simple
From inception to manufacturing. Consistent mechanism, conditions & geometry.
Robust & Simple to Operate
Technology that just works. No moving parts. No single-use plastic. No hassle.
Global Service
Rapid delivery. Unrivalled formulation expertise. Support throughout your journey.

Accelerate your product development journey with simplicity in scale

From Discovery to Manufacturing video

Play

Lipid Nanoparticles

Liposomes

PLGA Microspheres

Hydrogels

Core/Shell Systems

In the world of injectable therapeutics, your process is your product. Begin with the end in mind and start your formulation development journey with technology that scales seamlessly from benchtop high throughput screening to commerical scale continuous manufactuing with no consumables, no moving parts, and low energy burdens.

Server Render

Tell us about your challenge

At Micropore we partner for the life of your product, working together to solve formulation challenges and deliver the highest performing, most sustainable, most cost-effective drug product manufactuing systems.

Ask an expert

Latest from Micropore

Micropore Pathfinder™ device is a finalist in CPHI Pharma Awards 2023

18th September 2023

Micropore's Pathfinder™ DOE unit has been shortlisted in the Accelerating Innovation category of the prestigious CPHI’s Pharma Awards 2023. The winners will be announced at the CPHI Barcelona 2023 event, which is running from 24-26 October.

Samsung Biologics harnesses the capability of a Pathfinder™ Pro 250

4th August 2023

This week Micropore Technologies was delighted to complete the Factory Acceptance Testing before delivery of a Pathfinder™ Pro 250 to Samsung Biologics, an award-winning contract development and manufacturing CDMO, servicing the evolving needs of biopharmaceutical companies worldwide.

Join Micropore at the 2023 Lipid Nanoparticles development Europe Summit

12th July 2023

With lipid nanoparticles moving beyond mRNA vaccines, biopharma are racing against the clock to exploit clinical utility to deliver more complex payloads, while optimising scalability and product quality.

More News

Stay Informed

Keep up to date with innovations at Micropore. Sign up today to stay informed with innovations at Micropore and automatically receive the Micropore newsletter and webinar invites.

Alternatively, you can download the latest edition of the Micropore newsletter HERE.

Single Device

The AXF™mini. One device for discovery, preclinical & clinical stages. Start at 0.5mL or less. Turn it up to 10-20mL. And finally up-scale to 100’s mL.

Scale-up Made Simple

From inception to manufacturing. Consistent mechanism, conditions & geometry.

Robust & Simple to Operate

Technology that just works. No moving parts. No single-use plastic. No hassle.

Global Service

Rapid delivery. Unrivalled formulation expertise. Support throughout your journey.